T1	Treatment 38 62	receptor-γ pioglitazone
T2	Treatment 487 509	(PPAR-γ) pioglitazone
T3	Treatment 820 926	trial of 45 mg daily pioglitazone versus placebo, with a 3-month duration/arm and a 2-month washout period
T4	Treatment 1453 1476	treatment, pioglitazone
T5	Treatment 1618 1630	with placebo
T6	Treatment 1632 1653	Further, pioglitazone
T7	Treatment 1804 1828	Addition of pioglitazone
